Table 1.

Patient characteristics of infants with posterior zone I ROP

Infant number	Sex	GA (weeks)	BW (grams)	Post-natal age at first screening (Days)	PMA at first screening (Weeks)	Eye	TVL	NVI	Non-Dilating Pupil	Interval between IVR and laser (Days)	Time between Primary and supplemental laser ablation (Weeks) (if any)	Follow up period (months)	Outcome
1	F	27	1200	23	30	OD	A	P	A	29	-	18	1
						OS	A	P	A				1
2	M	26	830	21	29	OD	P	A	P	26	4	14	1
						OS	P	A	P	4			1
3	F	27	1155	23	30	OD	P	A	P	30	-	12	1
						OS	P	A	P				1
4	F	30	1150	20	33	OD	P	P	A	32	3	15	1
						OS	P	P	A	3			1
5	F	29	960	36	34	OD	P	P	P	29	-	14	1
						OS	P	P	P				1
6	M	27	1245	19	30	OD	P	P	A	26	-	13	1
						OS	P	P	A	3			1
7	F	32	1560	17	35	OD	P	A	P	30	-	11	1
						OS	P	A	P				1
8	M	26	785	39	31	OD	P	A	A	27	-	10	2
						OS	P	A	A				1
9	F	32	1770	20	35	OD	P	A	A	32	-	11	1
						OS	P	A	A				1
10	M	30	1300	22	33	OD	P	P	P	27	3	10	1
						OS	P	P	P	3			1
11	F	30	1415	20	33	OD	A	A	A	31	-	10	1
						OS	A	A	A				1
12	M	30	1100	20	33	OD	A	A	A	29	-	11	1
						OS	A	A	A				1
13	M	30	1200	23	33	OD	P	P	P	34	-	15	1
						OS	P	P	P				1
14	M	32	2003	14	34	OD	P	P	A	31	-	12	1
						OS	P	P	A				1
15	M	25	900	35	29	OD	P	A	P	24	4	9	1
						OS	P	A	P	4			1
16	F	29	1050	16	31	OD	P	P	P	33	3	7	2
						OS	P	P	P	3			1
17	M	29	900	52	36	OD	A	P	P	30	-	6	2
						OS	A	P	P				1
18	M	28	875	23	31	OD	P	A	A	29	2	6	1
						OS	P	A	A	2			1
19	M	28	1070	20	31	OD	P	A	A	33	-	6	1
						OS	P	A	A				1
20	M	26	1100	23	29	OD	P	P	P	31	-	6	1
						OS	P	P	P				1
21	M	27	1185	20	30	OD	P	P	P	31	-	6	1
						OS	P	P	P				1
22	M	29	1145	30	33	OD	A	P	P	29	-	6	1
						OS	A	P	P				1
23	M	28	1280	30	32	OD	P	P	A	29	-	6	1
						OS	P	P	A				1
24	F	28	1150	26	32	OD	A	A	A	29	-	6	1
						OS	A	A	A				1

F: Female, M: Male, GA: Gestational Age, BW: Birth Weight, PMA: Post Menstrual Age, TVL: Tunica Vasculosa Lentis, NVI: Neovascularization of Iris, A: Absent, P: Present, IVR: Intravitreal Ranibizumab, Outcome: 1- Favorable outcome, 2- Unfavorable outcome